New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
09:20 EDTMX, KTOS, HDY, PRMW, PAY, EXXI, EPL, FCEL, SNTA, GERN, RAD, QIWI, OXGN, EXPROn The Fly: Pre-market Movers
UP AFTER EARNINGS: VeriFone (PAY), up 8.5%... Primo Water (PRMW), up 8.3%... QIWI (QIWI), up 2.5%. ALSO HIGHER: Oxigene (OXGN), up 128% following results from its Phase 2 clinical trial evaluating Avastin with or without ZYBRESTAT to treat patients with recurrent ovarian cancer... Rite Aid (RAD), up 3% following upgrade at Goldman... EPL Oil & Gas (EPL), up 28.8% after Energy XXI (EXXI) to acquire the company for $2.3B. DOWN AFTER EARNINGS: Express (EXPR), down 13%... Kratos Defense (KTOS), down 10%. ALSO LOWER: Hyperdynamics (HDY), down 59% after U.S. Department of Justice and the SEC to open investigations into the activities of the company... Geron (GERN), down 61% after announcing IND clinical hold affecting trials of imetelstat... Synta Pharmaceuticals (SNTA), down 16.7% after downgraded at Stifel, BMO Capital... FuelCell (FCEL), down 3.6% following downgrade at Cowen... MagnaChip (MX), down 10.7% after announcing it will restate prior financial statements... Northwest Biotherapeutics (NWBO), down 6.8% following downgrade at Oppenheimer.
News For EXPR;OXGN;QIWI;RAD;GERN;SNTA;FCEL;EPL;EXXI;PAY;PRMW;HDY;KTOS;MX From The Last 14 Days
Check below for free stories on EXPR;OXGN;QIWI;RAD;GERN;SNTA;FCEL;EPL;EXXI;PAY;PRMW;HDY;KTOS;MX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
10:02 EDTFCELChina to replace new-energy vehicle subsidies with new program, China Daily says
China will launch more fiscal support policies for "new-energy" vehicles for 2016 to 2020 when the current subsidy program expired at the end of 2015, said China Daily, citing a notice the State Council released Monday. New-energy vehicles include pure electric ones, plug-in hybrids and fuel cell vehicles, the report noted. Makers of electric vehicles include Kandi (KNDI) and Tesla (TSLA) and companies in the fuel cell space include Plug Power (PLUG), FuelCell Energy (FCEL) and Ballard Power (BLDP). Reference Link
10:01 EDTSNTASynta Pharmaceuticals strength a selling opportunity, says Stifel
Subscribe for More Information
10:00 EDTQIWIOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with an Equal Weight at Morgan Stanley... Actinium Pharmaceuticals (ATNM) initiated with a Buy at Canaccord... Axys Technologies (AXYS) initiated with a Buy at Dougherty... Chambers Street Properties (CSG) initiated with a Neutral at SunTrust... Enphase Energy (ENPH) initiated with a Buy at Dougherty... Minerals Technologies (MTX) initiated with an Outperform at Wedbush... NextEra Energy Partners (NEP) initiated with a Buy at BofA/Merrill... PTC Therapeutics (PTCT) initiated with a Buy at BofA/Merrill... QIWI (QIWI) initiated with a Positive at Susquehanna... Quality Systems (QSII) initiated with a Buy at Topeka... Sarepta (SRPT) initiated with a Neutral at BofA/Merrill... Trinseo S.A. (TSE) initiated with a Buy at BofA/Merrill... Washington Prime Group (WPG) initiated with a Neutral at SunTrust... Zhaopin (ZPIN) initiated with a Buy at UBS.
09:08 EDTFCELOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Chipotle (CMG), up 10.7%... Crocs (CROX), up 5%... Lockheed Martin (LMT), up 1.4%. ALSO HIGHER: GreenHunter Resources (GRH), up 10.3% after announcing intent to form MLP... TG Therapeutics (TGTX), up 9.5% after reporting Q2 results, preclinical study results, price target on shares raised to $19 from $13 at Brean Capital... FuelCell (FCEL), up 5.4% after announcing German government support, EUR 4.9M in research awards... Apache (APA), up 5.2% after Bloomberg says activist investor JANA Partners disclosed $1B position in the stock. DOWN AFTER EARNINGS: Harley-Davidson (HOG), down 4.1%... Travelers (TRV), down 3.4%... McDonald's (MCD), down 2.3%... Coca-Cola (KO), down 2.5%. ALSO LOWER: Amazon.com (AMZN), down 1% following downgrade to Neutral rating at Citigroup.
09:07 EDTSNTASynta Pharmaceuticals data positive, says JMP Securities
JMP Securities believes that early top-line data indicates Synta's ganetespib plus current standard of care, low-dose Ara-C provide clinical benefit in high-risk elderly patients with newly diagnosed AML and MDS. The firm says the results increase its confidence in a positive GALAXY-2 outcome in NSCLC and broad applicability of ganetespib across a variety of tumor types. It keeps an Outperform rating on the stock.
07:13 EDTFCELFuelCell announces German government support, EUR 4.9M in research awards
Subscribe for More Information
July 21, 2014
19:21 EDTQIWIQIWI initiated with a Positive at Susquehanna
Subscribe for More Information
16:32 EDTSNTASynta Pharmaceuticals advances ganetespib into Phase 3 extension of AML LI-1
Synta Pharmaceuticals announced the advancement of ganetespib into the Phase 3 extension of the AML LI-1 trial. AML LI-1 is a multicenter, randomized Phase 2/3 clinical study evaluating several novel treatment regimens, including the combination of ganetespib with low dose cytarabine, in newly diagnosed elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome who are not eligible for intensive chemotherapy. Ganetespib is a next-generation inhibitor of the chaperone protein Hsp90, which is critical for the activation and stability of numerous proteins that drive cancer growth and proliferation. Ganetespib has been studied in over 1000 patients to date. Advancement into the Phase 3 extension follows an interim analysis of results from 50 patients who received the ganetespib-cytarabine combination in the Phase 2 portion of the trial. The primary efficacy outcome in Phase 2 was rate of complete response. Per protocol, the Phase 3 extension will include an interim futility analysis and enroll approximately 200 patients in the ganetespib-cytarabine and the cytarabine alone arms, for a total of approximately 400 patients. The primary efficacy endpoint for the Phase 3 extension will include overall survival. The Company is currently in discussion with study investigators, and anticipates providing additional details, including the timing of study milestones, as they become formalized. The AML LI-1 trial is the first of three multicenter, randomized studies supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK to include a ganetespib treatment arm. AML LI-1 is being conducted under the auspices of the UKs National Cancer Research Institute Haematological Oncology Study Group, with investigators in Denmark, France, New Zealand, and the UK, and under the sponsorship of Cardiff University, UK. The other two studies, to be initiated later this year, are the AML-18 trial, evaluating ganetespib with standard DA in patients over 60 years old who can tolerate intensive chemotherapy, and the AML-19 trial, evaluating ganetespib in combination with conventional chemotherapy in younger patients with AML.
16:15 EDTEXPRExpress CEO Michael Weiss to retire in 2015, David Kornberg tapped as successor
Subscribe for More Information
11:04 EDTEXPROptions with increasing implied volatility:
Subscribe for More Information
July 18, 2014
15:23 EDTFCELJapan to provide generous subsidies for fuel cell vehicles, Nikkei says
Subscribe for More Information
10:15 EDTFCELPlug Power advances after analyst says outlook has improved
Subscribe for More Information
09:18 EDTEXPRFBR Capital 'skeptical' of Sycamore interest in Fred's
Subscribe for More Information
July 15, 2014
13:15 EDTFCELPlug Power jumps after analyst starts with Outperform rating
Subscribe for More Information
07:08 EDTQIWIQIWI price target raised to $62 from $50 at JPMorgan
Subscribe for More Information
07:03 EDTKTOSKratos Defense awarded contract by U.S. Army with potential value of $34.77M
Kratos Defense announced that its Micro Systems subsidiary of the Advanced Drone and Targets Systems, or ADTS, Division recently received a five-year contract from the U.S. Army valued at up to $34.77M for unmanned drone system command, control and communication systems, solutions and services. Under the new award, Kratos will be issued task orders to provide engineering and technical support to develop technology and system upgrades for U.S. Army unmanned ground, sea surface, and aerial drones and target vehicles, command, and communication system electronics and related ground control stations. This new single contract award has a one base year and four option year period of performance.
July 14, 2014
09:33 EDTQIWIQIWI initiated with a Buy at Deutsche Bank
Target $60.
07:07 EDTKTOSKratos Defense receives $4.2M unmanned aerial drone system contract award
Subscribe for More Information
July 11, 2014
06:00 EDTRADStocks with implied volatility below IV index mean; RAD BBBY
Stocks with implied volatility below IV index mean; Rite Aid (RAD) 36, Bed Bath & Beyond (BBBY) 18 according to iVolatility.
July 10, 2014
06:00 EDTPAYeBay repatriated cash likely to be used for M&A, says Piper Jaffray
Piper Jaffray believes a large part of the $9B in cash eBay expects to repatriate to the U.S. will be used for acquisitions in the payments space. The cash, equating to $6B net of taxes, could help eBay take advantage of the shift to mobile payments, the firm says. Piper lists Square, VeriFone (PAY), iZettle and Corduro as companies in the payment space that are within acquisition range for eBay. The firm has an Overweight rating on eBay with a $63 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use